Who are MediciNova, Inc.'s main suppliers?

MediciNova, Inc. (MNOV) key suppliers include: LUCID-CAPITAL-MARKETS-LLC, TAISHO-PHARMACEUTICAL-CO-LTD, Sanofi. View the full supplier network at chainsifter.com/chain/MNOV.

Who are MediciNova, Inc.'s major customers?

MediciNova, Inc. (MNOV) key customers include: MAYO-FOUNDATION-FOR-MEDICAL-EDUCATION-AND-RESEAR. View the full customer network at chainsifter.com/chain/MNOV.

What sector is MediciNova, Inc. in?

MediciNova, Inc. (MNOV) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

MediciNova, Inc. Suppliers, Customers & Supply Chain (MNOV)

3Suppliers

1Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

MediciNova, Inc. (MNOV) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

7Total relationships

4Distinct source URLs

6High confidence

0.880Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

MediciNova, Inc. Suppliers

Ticker	Name	Confidence	Evidence
LUCID-CAPITAL-MARKETS-LLC	LUCID-CAPITAL-MARKETS-LLC	92%	the Company entered into an equity distribution agreement with Lucid Capital Markets, LLC (the "Agent") to sell shares of the Company's common stock
TAISHO-PHARMACEUTICAL-CO-LTD	TAISHO-PHARMACEUTICAL-CO-LTD	92%	For the MN-166 (ibudilast) development program, we have historically sourced and imported delayed-release ibudilast capsules, marketed in Japan as Pinatos®, from Taisho.
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from MNOV graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from MNOV graph: Reciprocal relationship from SNYN…

MediciNova, Inc. Customers

Ticker	Name	Confidence	Evidence
MAYO-FOUNDATION-FOR-MEDICAL-EDUCATION-AND-RESEAR	MAYO-FOUNDATION-FOR-MEDICAL-EDUCATION-AND-RESEAR	90%	In December 2024, the Company entered into an agreement with Mayo Foundation for Medical Education and Research (Mayo), to support clinical research services to evaluate the efficacy of MN-166 (ibudi…

MediciNova, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
MNOV-DEBT-11034	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2012-12-31.
MNOV-DEBT	Debt stack $165,198	90%	Market cache reports total debt of $165,198.

MediciNova, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for MediciNova, Inc..

MediciNova, Inc. Ownership

Holder	Name	Confidence	Evidence
MNOV-OWNER-BARCLAYS-PLC	BARCLAYS PLC	90%	13F overlay lists BARCLAYS PLC as top holder; 30 tracked holders.

MediciNova, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SNYNF	Sanofi	100.00	1	['supplier']
ANL	Adlai Nortye Ltd.	50.00	2
DBVTF	DBV TECHNOLOGIES	50.00	2
CYTOF	Altamira Therapeutics Ltd.	50.00	2
CRVS	Corvus Pharmaceuticals, Inc.	50.00	2
BIOA	BioAge Labs, Inc.	50.00	2
CYTK	Cytokinetics, Incorporated	50.00	2
CBIO	Crescent Biopharma, Inc.	50.00	2
DNTH	Dianthus Therapeutics, Inc.	50.00	2
CCEP	Coca-Cola Europacific Partners PLC	50.00	2
DSGN	Design Therapeutics, Inc.	50.00	2
AZN	AstraZeneca PLC	50.00	2
CLDX	Celldex Therapeutics, Inc.	50.00	2
DYN	Dyne Therapeutics, Inc.	50.00	2
ANRO	Alto Neuroscience, Inc.	50.00	2
LGND	Ligand Pharmaceuticals Incorporated	50.00	2
EDIT	Editas Medicine, Inc.	50.00	2
FULC	Fulcrum Therapeutics, Inc.	50.00	2
ATOS	Atossa Therapeutics, Inc.	50.00	2
ALXO	ALX Oncology Holdings Inc.	50.00	2

MediciNova, Inc. Supply Chain